Result of General Meeting

RNS Number : 3724L
Omega Diagnostics Group PLC
18 July 2017
 

 

18 July 2017

 

Omega Diagnostics Group plc

 

Result of General Meeting

 

Further to Omega's announcement of 30 June 2017, the Company is pleased to announce today the passing of the Resolutions at the General Meeting held earlier today. The Placing, Subscription and Open Offer remain conditional on Admission of the New Ordinary Shares to AIM which is expected to take place at 8.00 a.m. tomorrow.

 

With effect from Admission the Company will have 126,884,060 Ordinary Shares in issue, with no shares held in treasury. Shareholders may use this figure as the denominator by which they are required to notify their interest in, or change to their interest in, the Company under the Disclosure Guidance and Transparency Rules.

 

Capitalised terms not otherwise defined in the text of this announcement have the meanings given to them in the Company's circular dated 30 June 2017.

 

Contacts:

 Omega Diagnostics Group PLC                         

Tel: 01259 763 030

Andrew Shepherd, Chief Executive                             

www.omegadiagnostics.com

Kieron Harbinson, Group Finance Director

 

Jag Grewal, Group Sales and Marketing Director                                                  

 

 

 

finnCap Ltd                                              

Tel: 020 7220 0500

Geoff Nash/James Thompson (Corporate Finance)

 

Mia Gardner (Corporate Broking)

 

 

 

Walbrook PR Limited

Tel: 020 7933 8780 or omega@walbrookpr.com

Paul McManus

Mob: 07980 541 893

Lianne Cawthorne

Mob: 07584 391 303

 

 

Accordingly, the Company makes the following announcement and notification in accordance with the EU Market Abuse Regulation (No 596/2014):

1.

Details of Persons Discharging Managerial Responsibilities "PDMR" / person closely associated with them ('PCA')

a)

Name

David Evans

2.

Reason for notification

b)

Position / status

Non-Executive Chairman

c)

Initial notification / amendment

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

b)

Name

Omega Diagnostics Group plc

c)

LEI

2138007U9P4BTZTYIR92

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 

Identification code

 

ordinary shares of 4p each

 

 

GB00B1VCP282

b)

Nature of the transaction

Acquisition of shares pursuant to the Placing

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£0.18

1,111,111

 

 

d)

Aggregated information

Aggregated volume Price

n/a

e)

Date of the transaction

19 July 2017

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 

1.

Details of Persons Discharging Managerial Responsibilities "PDMR" / person closely associated with them ('PCA')

a)

Name

Andrew Shepherd

2.

Reason for notification

b)

Position / status

Chief Executive Officer

c)

Initial notification / amendment

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

b)

Name

Omega Diagnostics Group plc

c)

LEI

2138007U9P4BTZTYIR92

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 

Identification code

 

ordinary shares of 4p each

 

 

GB00B1VCP282

b)

Nature of the transaction

Acquisition of shares pursuant to the Placing

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£0.18

111,111

 

 

d)

Aggregated information

Aggregated volume Price

n/a

e)

Date of the transaction

19 July 2017

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 

1.

Details of Persons Discharging Managerial Responsibilities "PDMR" / person closely associated with them ('PCA')

a)

Name

Kieron Harbinson

2.

Reason for notification

b)

Position / status

Finance Director

c)

Initial notification / amendment

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

b)

Name

Omega Diagnostics Group plc

c)

LEI

2138007U9P4BTZTYIR92

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 

Identification code

 

ordinary shares of 4p each

 

 

GB00B1VCP282

b)

Nature of the transaction

Acquisition of shares pursuant to the Placing

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£0.18

55,555

 

 

d)

Aggregated information

Aggregated volume Price

n/a

e)

Date of the transaction

19 July 2017

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 

1.

Details of Persons Discharging Managerial Responsibilities "PDMR" / person closely associated with them ('PCA')

a)

Name

Jag Grewal

2.

Reason for notification

b)

Position / status

Sales & Marketing Director

c)

Initial notification / amendment

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

b)

Name

Omega Diagnostics Group plc

c)

LEI

2138007U9P4BTZTYIR92

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 

Identification code

 

ordinary shares of 4p each

 

 

GB00B1VCP282

b)

Nature of the transaction

Acquisition of shares pursuant to the Placing

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£0.18

53,333

 

 

d)

Aggregated information

Aggregated volume Price

n/a

e)

Date of the transaction

19 July 2017

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 

1.

Details of Persons Discharging Managerial Responsibilities "PDMR" / person closely associated with them ('PCA')

a)

Name

Colin King

2.

Reason for notification

b)

Position / status

Chief Operating Officer

c)

Initial notification / amendment

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

b)

Name

Omega Diagnostics Group plc

c)

LEI

2138007U9P4BTZTYIR92

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 

Identification code

 

ordinary shares of 4p each

 

 

GB00B1VCP282

b)

Nature of the transaction

Acquisition of shares pursuant to the Placing

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£0.18

277,777

 

d)

Aggregated information

Aggregated volume Price

n/a

e)

Date of the transaction

19 July 2017

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ROMKVLBFDDFXBBB
UK 100